Meet the editor

Dr. Bruna Maria Roesler is a pharmacist biochemist and holds a Master's degree in Pharmacology and a Doctoral degree in Basic Sciences—Internal Medicine from the State University of Campinas (Campinas, SP, Brazil) where she has identified the principal genotypes of *Helicobacter pylori* strains in patients with chronic gastritis, peptic ulcer disease, and gastric cancer (early and advanced stages) through molecular biology techniques. She

has published her work in several peer-reviewed journals and given oral and poster presentations at various congresses. Her research also includes the etiology, epidemiology, and physiopathology of gastrointestinal diseases. She has also participated in studies that reported the possible relationship between *H. pylori* and idiopathic thrombocytopenic purpura, as well as between *H. pylori* and liver diseases.

Contents

**Section 1**

**Section 2**

**Section 3**

*Helicobacter pylori* Infection

*and Hirofumi Shimomura*

**Preface III**

*Helicobacter pylori*: General Comments **1**

**Chapter 1 3**

**Chapter 2 25**

Diversity of Tretaments for *H. pylori* Infection Worldwide **39**

**Chapter 3 41** Development of a Novel Antibacterial Medicine that Targets a Characteristic

**Chapter 4 57**

**Chapter 5 73**

Autoimmune Gastritis **91**

**Chapter 6 93**

*by Todor Asenov Angelov, Mila Dimitrova Kovacheva-Slavova, Hristo Ilianov Iliev,* 

*Hristo Yankov Valkov and Borislav Georgiev Vladimirov*

*Helicobacter pylori*: A Pathogen of Ample Risk to Health *by Isidro Favian Bayas-Morejón, Rosa Angélica Tigre-León, Edison Riveliño Ramón-Curay and Darwin Alberto Núñez-Torres*

Lipid of the Cell Membranes of *Helicobacter pylori by Kiyofumi Wanibuchi, Hisashi Masui, Takashi Takahashi* 

*by Balaji Ommurugan and Vanishree Rao*

Gastritis Treated by Chinese Medicine *by Xiaomei Wang, Guang Ji and Huangan Wu*

Current View on Autoimmune Gastritis

Pharmacotherapy of Peptic Ulcer Disease and Latest Research

*by Mila Dimitrova Kovacheva-Slavova, Todor Asenov Angelov,* 

*Hristo Yankov Valkov, Hristo Ilianov Iliev and Borislav Georgiev Vladimirov*

## Contents


Preface

This edited volume is a collection of reviewed and relevant research chapters concerning developments within the gastritis—new approaches and treatments field of study. The book includes scholarly contributions by various authors and is edited by a group of experts pertinent to gastritis, gastric carcinogenesis, and new approaches in diagnoses and treatments. Each contribution comes as a separate chapter complete in itself but directly related to the book's topics and objectives.

The book is divided into three sections: *Helicobacter pylori*: *General Comments*, *Diversity of Treatments for H. pylori Infection Worldwide*, and *Autoimmune Gastritis*.

The section *Helicobacter pylori*: *General Comments* includes chapters dealing with *Helicobacter pylori* Infection and *Helicobacter pylori*: A Pathogen of Ample Risk to

The following section, *Diversity of Treatments for H. pylori Infection Worldwide*, includes Development of a Novel Antibacterial Medicine that Targets a Characteristic Lipid of the Cell Membranes of Helicobacter pylori, Pharmacotherapy of Peptic Ulcer Disease and Latest Research, and Gastritis Treated by Chinese Medicine.

Current View on Autoimmune Gastritis is included in the last section of this book,

**IntechOpen**

The target audience comprises scholars and specialists in the field.

Health.

*Autoimmune Gastritis*.
